Novavax, Inc. is an American vaccine development company headquartered in Gaithersburg, Maryland, with additional facilities in Rockville, Maryland and Uppsala, Sweden. As of 2020, it has an ongoing Phase III clinical trial in older adults for its candidate vaccine for seasonal influenza, NanoFlu and a candidate vaccine for prevention of COVID-19. In June 2013, Novavax acquired the Matrix-M adjuvant platform with the purchase of Swedish company Isconova AB and renamed its new subsidiary Novavax AB.

NOVAVAX, INC. (NASDAQ:NVAX) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Novavax, Inc.

NVAX DEADLINE: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Novavax, Inc. of Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial Losses to Contact the Firm

A new study finds that most COVID-19 vaccines boost immunity, though there is no winning shot

The 'Highly Mutated Virus' Signals A Need For Annual Shots: BioNTech CEO

COVID: We need to stop wearing cloth masks and go to N95s for all, expert says

NVAX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of January 11, 2022 in the Class Action Filed on Behalf of Novavax, Inc. Limited Shareholders

INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Novavax, Inc. with Losses of $100,000 to Contact the Firm

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment Novavax, Inc. of Class Action Lawsuit and Upcoming Deadline - NVAX

NOVAVAX SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Novavax, Inc.  NVAX

NVAX Investor Alert: Shareholder Class Action Lawsuit Filed

3 Stocks to Buy for the New COVID Variant

NOVAVAX, INC. (NASDAQ: NVAX) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Novavax, Inc.

'Investors need to take a longer term perspective' amid market volatility, strategist says

Biden's new plan COVID-19 plan includes 'two new points,' analyst explains

President Biden outlines steps to combat COVID-19 in winter

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Novavax, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Doctor: U.S. needs to prepare for a potential perfect storm' between Omicron variant and winter

Why Novavax Stock Is in Retreat Mode Today

Novavax tailoring Covid-19 vaccine to Omicron variant while advancing campus expansion plans

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Novavax, Inc. (NVAX) Investors

Top Streaming News